Table 2 Subgroup analysis to investigate types of tuberculosis resistance in patients with gender segregation
From: Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis
Type | Sex | Number of articles | Sample size | I2 | Begg and Mazumdar correlation test | Prevalence % (95% CI) |
|---|---|---|---|---|---|---|
Multi-drug resistant TB | Male | 24 | 7240 | 98.6 | P = 0.413 | 20 (11.9–31.8) |
Female | 22 | 3948 | 95.6 | P = 0.611 | 13 (8.3–19.8) | |
Isoniazid resistant TB | Male | 10 | 5312 | 98.9 | P = 0.21 | 17.5 (9.6–29.8) |
Female | 9 | 4046 | 95.7 | P = 0.602 | 11.6 (7.3–18) | |
Rifampin-resistant TB | Male | 11 | 7555 | 99.1 | P = 0.876 | 12.7 (5.7–25.9) |
Female | 10 | 9637 | 96.6 | P = 0.591 | 8.8 (5.6–13.7) |